Your Monthly Medicines Roundup for March 2024

Your Monthly Medicines Roundup for March 2024

It has been another quiet month in terms of public announcements for newly assessed metabolic medicines.

We are currently awaiting the announcements from AWSMG, Health NI, NICE and SMC for several different indication, among which, in alphabetical order: 

Neimman-Pick

Niemann-Pick – Olipudase alfa for treating Niemann-Pick type A or type B is currently being assessed by NICE. Unfortunately, preliminary documentation shows that NICE is currently not set to approve this new treatment. 

For further details, click the button below:

Phenylketonuria

Sapropterin for treating phenylketonuria is currently being assessed by Health NI. We know from our friends at NSPKU that Sapropterin is set so be accessible to all age groups in Northern Ireland.

For further details, click the button below:

Skip to content